Anti-vascular endothelial growth factor (VEGF) and anti-angiogenic agents: Bevacizumab and tyrosine kinase inhibitors can cause glomerular microangiopathy (G-TMA) manifesting as hypertension, proteinuria, and renal dysfunction. This evidence concerns the gene VEGFA and Abnormal renal physiology.